Pharmaceuticals: A New Frontier in Investment Treaty Arbitration

Reprinted with permission from Global Arbitration Review.

Until recently, pharmaceutical companies had not sought to advance or protect their interests through investment treaty arbitration. However, the potential for pharmaceutical companies that invest abroad to use this form of arbitration against foreign governments to help overcome unfair regulatory obstacles and political risks is evidenced through a number of arbitrations recently brought by major US, Canadian and French companies.